Drug intelligence / Profile preview

1-(biphenyl-4-ylmethyl)-1H-imidazole

Development stage: Unknown
Modality: Small Molecules

Overview

**Description:** 1-(biphenyl-4-ylmethyl)-1H-imidazole is a synthetic small molecule belonging to the class of biphenyl derivatives and imidazoles. It has the molecular formula C16H14N2 and a molecular weight of approximately 234.29 g/mol[2][4]. The compound is listed as experimental, with no approved medical indications or clinical trial activity reported to date[1][2][4]. Its mechanism of action, pharmacological properties, and therapeutic potential have not been established in humans. There are no known brand names or marketed formulations for this compound.

Other names: 1-(biphenyl-4-ylmethyl)-1H-imidazole1-((4-phenylphenyl)methyl)-1H-imidazole1-[biphenyl-4-methyl]-1H-imidazole56643-79-9

Beyond the preview

Go deeper on 1-(biphenyl-4-ylmethyl)-1H-imidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-(biphenyl-4-ylmethyl)-1H-imidazole.

Explore the full profile